Colitis ulcerative+1
RecruitingStudy of adalimumab and infliximab dose adjustment guided by fecal calprotectin monitoring in adolescents and young adults with Crohn's disease or ulcerative colitis
Study of adalimumab and infliximab dose adjustment guided by fecal calprotectin monitoring in adolescents and young adults with Crohn's disease or ulcerative colitis
- Disease:Colitis ulcerativeCrohn's disease
- Substances:AdalimumabInfliximab
Belgium- Participants:0–17 years · 18–64 years
- Substances:Adalimumab
- Sponsor:Universitair Medisch Centrum Groningen










